Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study

Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study

ABSTRACT Cardiovascular diseases are the leading cause of mortality worldwide, with dyslipidemia as a major modifiable risk factor. This study aimed to assess 25‐year trends in lipid‐lowering agent consumption in Croatia from 2000 to 2023. We conducted a population‐based analysis using IMS and IQVIA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrej Belančić, Marta Kučan Štiglić, Luka Prgomet, Ivan Pećin, Željko Reiner, Dinko Vitezić
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Pharmacology Research & Perspectives
Subjects:	cholesterol dyslipidemia lipid‐lowering agents statins
Online Access:	https://doi.org/10.1002/prp2.70122
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review
by: Chaitanya Bhatt, et al.
Published: (2024-04-01)

Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity
by: Barbara Gordon‐Kundu, et al.
Published: (2025-01-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Three-year dynamics and unsolved problems of lipid-lowering therapy
by: V. A. Sergeeva
Published: (2015-11-01)

Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)

Triglyceride/high density lipoprotein cholesterol index and future cardiovascular events in diabetic patients without known cardiovascular disease
by: Ryosuke Nakashima, et al.
Published: (2025-03-01)

LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)
by: N. M. Akhmedzhanov, et al.
Published: (2016-05-01)

Lipid-lowering therapy: modern possibilities and real clinical practice
by: A. V. Blokhina, et al.
Published: (2022-09-01)

The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection
by: Omer Qutaiba B. Allela, et al.
Published: (2024-12-01)

Cardiovascular risk management beyond statins: review of new therapies available in Italy
by: Maurizio Capuozzo, et al.
Published: (2025-07-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)

The treatment of cholesterol: issues, effects and targets
by: James A. Ker
Published: (2010-12-01)

MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins: Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01)

New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist
by: A. B. Skiba, et al.
Published: (2023-12-01)

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review
by: Subodh Bashyal, et al.
Published: (2025-07-01)

Statin Intolerance and Adverse Effects in Lipid-Lowering Therapy – Pathomechanisms, Management Strategies, and Alternative Treatment Approaches
by: Natalia Śliwa, et al.
Published: (2025-06-01)

Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review
by: Dominik Strikic, et al.
Published: (2025-06-01)

Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
by: A. N. Britov, et al.
Published: (2011-02-01)

Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
by: L. R. Gazdanova, et al.
Published: (2010-04-01)

Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01)

TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01)

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
by: Berezin A.E., et al.
Published: (2015-06-01)

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
by: Haifeng Yu, et al.
Published: (2024-12-01)

Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01)

Lipid-lowering effect of combined therapy with high-intensity statins and CETP inhibitors: a Systematic Review and meta-analysis
by: Liubo Xiang, et al.
Published: (2025-05-01)

CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
by: Dmytro D. Diachuk, et al.
Published: (2025-04-01)

Serum lipid profile abnormalities among beta-thalassemia patients: a systematic review and meta-analysis
by: Sagad O. O. Mohamed, et al.
Published: (2024-11-01)

Comparative study of lipid profile among type 2 diabetics on treatment within Owo, metropolis, Nigeria.
by: Olaniyan, O.O., Adebayo T.O., Onyiba G.A., Atere A.D., Obot A.S., Ajayi A.A., Adedokun A.A., Shoyinka S.D., Yekeen S.B., and Abidoye O.J.
Published: (2024-01-01)

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?
by: S. K. Zyryanov, et al.
Published: (2020-09-01)

Clinical decision support system for lipid metabolism disorders: relevance and potential
by: A. S. Alieva, et al.
Published: (2021-07-01)

Lipid-lowering therapy in outpatients of different ages with coronary artery disease
by: S. K. Zyryanov, et al.
Published: (2020-11-01)

Diabetic retinopathy and dyslipidemia among patients with type 2 diabetes mellitus in the Jazan endocrine and diabetes center: A case-control study
by: Mansor Bayydih, et al.
Published: (2025-06-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS AFTER HEART TRANSPLANTATION: STATINS
by: A. О. Shevchenko
Published: (2016-06-01)

Lipid Metabolism and Statin Therapy in Neurodegenerative Diseases: An Endocrine View
by: Antonella Di Sarno, et al.
Published: (2025-04-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

Association between periodontitis and blood lipid levels: a cross-sectional study
by: Feiya Zhao, et al.
Published: (2025-07-01)

ABNORMAL BLOOD LIPIDS LEVELS (DYSLIPIDEMIA) TREATMENT WITH ACUPUNCTURE METHOD
by: Anissa Maulina Rinjani, et al.
Published: (2022-03-01)